92 related articles for article (PubMed ID: 16503138)
1. Discovery of novel biaryl heterocyclic EP1 receptor antagonists.
Hall A; Bit RA; Brown SH; Chaignot HM; Chessell IP; Coleman T; Giblin GM; Hurst DN; Kilford IR; Lewell XQ; Michel AD; Mohamed S; Naylor A; Novelli R; Skinner L; Spalding DJ; Tang SP; Wilson RJ
Bioorg Med Chem Lett; 2006 May; 16(10):2666-71. PubMed ID: 16503138
[TBL] [Abstract][Full Text] [Related]
2. Novel methylene-linked heterocyclic EP1 receptor antagonists.
Hall A; Bit RA; Brown SH; Chowdhury A; Giblin GM; Hurst DN; Kilford IR; Lewell X; Naylor A; Scoccitti T
Bioorg Med Chem Lett; 2008 Mar; 18(5):1592-7. PubMed ID: 18262416
[TBL] [Abstract][Full Text] [Related]
3. Heterocyclic 1,7-disubstituted indole sulfonamides are potent and selective human EP3 receptor antagonists.
Hategan G; Polozov AM; Zeller W; Cao H; Mishra RK; Kiselyov AS; Ramirez J; Halldorsdottir G; Andrésson T; Gurney ME; Singh J
Bioorg Med Chem Lett; 2009 Dec; 19(23):6797-800. PubMed ID: 19836233
[TBL] [Abstract][Full Text] [Related]
4. Discovery of novel aminothiadiazole amides as selective EP(3) receptor antagonists.
Hilfiker MA; Wang N; Hou X; Du Z; Pullen MA; Nord M; Nagilla R; Fries HE; Wu CW; Sulpizio AC; Jaworski JP; Morrow D; Edwards RM; Jin J
Bioorg Med Chem Lett; 2009 Aug; 19(15):4292-5. PubMed ID: 19487124
[TBL] [Abstract][Full Text] [Related]
5. Discovery of novel, non-acidic 1,5-biaryl pyrrole EP1 receptor antagonists.
Hall A; Atkinson S; Brown SH; Chessell IP; Chowdhury A; Giblin GM; Goldsmith P; Healy MP; Jandu KS; Johnson MR; Michel AD; Naylor A; Sweeting JA
Bioorg Med Chem Lett; 2007 Mar; 17(5):1200-5. PubMed ID: 17196385
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a novel indole series of EP1 receptor antagonists by scaffold hopping.
Hall A; Billinton A; Brown SH; Chowdhury A; Giblin GM; Goldsmith P; Hurst DN; Naylor A; Patel S; Scoccitti T; Theobald PJ
Bioorg Med Chem Lett; 2008 Apr; 18(8):2684-90. PubMed ID: 18378447
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships of 1,5-biaryl pyrroles as EP1 receptor antagonists.
Hall A; Atkinson S; Brown SH; Chessell IP; Chowdhury A; Clayton NM; Coleman T; Giblin GM; Gleave RJ; Hammond B; Healy MP; Johnson MR; Michel AD; Naylor A; Novelli R; Spalding DJ; Tang SP
Bioorg Med Chem Lett; 2006 Jul; 16(14):3657-62. PubMed ID: 16697196
[TBL] [Abstract][Full Text] [Related]
8. 1,5-Biaryl pyrrole derivatives as EP1 receptor antagonists: Structure-activity relationships of 4- and 5-substituted benzoic acid derivatives.
Hall A; Brown SH; Chessell IP; Chowdhury A; Clayton NM; Coleman T; Giblin GM; Hammond B; Healy MP; Johnson MR; Metcalf A; Michel AD; Naylor A; Novelli R; Spalding DJ; Sweeting J
Bioorg Med Chem Lett; 2007 Feb; 17(3):732-5. PubMed ID: 17098427
[TBL] [Abstract][Full Text] [Related]
9. Non-acidic pyrazole EP1 receptor antagonists with in vivo analgesic efficacy.
Hall A; Billinton A; Brown SH; Clayton NM; Chowdhury A; Giblin GM; Goldsmith P; Hayhow TG; Hurst DN; Kilford IR; Naylor A; Passingham B; Winyard L
Bioorg Med Chem Lett; 2008 Jun; 18(11):3392-9. PubMed ID: 18462938
[TBL] [Abstract][Full Text] [Related]
10. 2,3-Diarylthiophenes as selective EP1 receptor antagonists.
Ducharme Y; Blouin M; Carrière MC; Chateauneuf A; Côté B; Denis D; Frenette R; Greig G; Kargman S; Lamontagne S; Martins E; Nantel F; O'Neill G; Sawyer N; Metters KM; Friesen RW
Bioorg Med Chem Lett; 2005 Feb; 15(4):1155-60. PubMed ID: 15686932
[TBL] [Abstract][Full Text] [Related]
11. EP1 antagonists for the treatment of inflammatory pain.
Hall A; Billinton A; Giblin GM
Curr Opin Drug Discov Devel; 2007 Sep; 10(5):597-612. PubMed ID: 17786859
[TBL] [Abstract][Full Text] [Related]
12. 1,5-Biaryl pyrrole derivatives as EP1 receptor antagonists. Structure-activity relationships of 6-substituted and 5,6-disubstituted benzoic acid derivatives.
Hall A; Brown SH; Chessell IP; Chowdhury A; Clayton NM; Coleman T; Giblin GM; Hammond B; Healy MP; Johnson MR; Metcalf A; Michel AD; Naylor A; Novelli R; Spalding DJ; Sweeting J; Winyard L
Bioorg Med Chem Lett; 2007 Feb; 17(4):916-20. PubMed ID: 17175160
[TBL] [Abstract][Full Text] [Related]
13. The discovery of 6-[2-(5-chloro-2-{[(2,4-difluorophenyl)methyl]oxy}phenyl)-1-cyclopenten-1-yl]-2-pyridinecarboxylic acid, GW848687X, a potent and selective prostaglandin EP1 receptor antagonist for the treatment of inflammatory pain.
Giblin GM; Bit RA; Brown SH; Chaignot HM; Chowdhury A; Chessell IP; Clayton NM; Coleman T; Hall A; Hammond B; Hurst DN; Michel AD; Naylor A; Novelli R; Scoccitti T; Spalding D; Tang SP; Wilson AW; Wilson R
Bioorg Med Chem Lett; 2007 Jan; 17(2):385-9. PubMed ID: 17084082
[TBL] [Abstract][Full Text] [Related]
14. Discovery of brain penetrant, soluble, pyrazole amide EP1 receptor antagonists.
Hall A; Billinton A; Bristow AK; Brown SH; Chowdhury A; Cutler L; Giblin GM; Goldsmith P; Hayhow TG; Kilford IR; Naylor A; Passingham B; Rawlings DA
Bioorg Med Chem Lett; 2008 Jul; 18(14):4027-32. PubMed ID: 18571922
[TBL] [Abstract][Full Text] [Related]
15. Discovery of a series of acrylic acids and their derivatives as chemical leads for selective EP3 receptor antagonists.
Asada M; Obitsu T; Nagase T; Sugimoto I; Yamaura Y; Sato K; Narita M; Ohuchida S; Nakai H; Toda M
Bioorg Med Chem; 2009 Sep; 17(18):6567-82. PubMed ID: 19700331
[TBL] [Abstract][Full Text] [Related]
16. Discovery of GSK345931A: An EP(1) receptor antagonist with efficacy in preclinical models of inflammatory pain.
Hall A; Brown SH; Budd C; Clayton NM; Giblin GM; Goldsmith P; Hayhow TG; Hurst DN; Naylor A; Anthony Rawlings D; Scoccitti T; Wilson AW; Winchester WJ
Bioorg Med Chem Lett; 2009 Jan; 19(2):497-501. PubMed ID: 19036582
[TBL] [Abstract][Full Text] [Related]
17. Identification and optimization of novel 1,3,4-oxadiazole EP1 receptor antagonists.
Hall A; Brown SH; Chowdhury A; Giblin GM; Gibson M; Healy MP; Livermore DG; Wilson RJ; Naylor A; Rawlings DA; Roman S; Ward E; Willay C
Bioorg Med Chem Lett; 2007 Aug; 17(16):4450-5. PubMed ID: 17574410
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel glycine sulfonamide antagonists for the EP1 receptor.
McKeown SC; Hall A; Blunt R; Brown SH; Chessell IP; Chowdhury A; Giblin GM; Healy MP; Johnson MR; Lorthioir O; Michel AD; Naylor A; Lewell X; Roman S; Watson SP; Winchester WJ; Wilson RJ
Bioorg Med Chem Lett; 2007 Mar; 17(6):1750-4. PubMed ID: 17236765
[TBL] [Abstract][Full Text] [Related]
19. Discovery of diphenyloxazole and Ndelta-Z-ornithine derivatives as highly potent and selective human prostaglandin EP(4) receptor antagonists.
Hattori K; Tanaka A; Fujii N; Takasugi H; Tenda Y; Tomita M; Nakazato S; Nakano K; Kato Y; Kono Y; Murai H; Sakane K
J Med Chem; 2005 May; 48(9):3103-6. PubMed ID: 15857112
[TBL] [Abstract][Full Text] [Related]
20. Discovery of heteroaryl sulfonamides as new EP1 receptor selective antagonists.
Naganawa A; Matsui T; Saito T; Ima M; Tatsumi T; Yamamoto S; Murota M; Yamamoto H; Maruyama T; Ohuchida S; Nakai H; Kondo K; Toda M
Bioorg Med Chem; 2006 Oct; 14(19):6628-39. PubMed ID: 16784865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
